AUGUST
- Trametinib Dimethyl Sulfoxide Tablets 0.5mg (base) and 2mg (base)
Approved: August 6, 2024 – Novugen Pharma (USA) LLC
Treatment for: Cancer
Generic for: Mekinist - Lofexidine Hydrochloride Tablets 0.18mg (base)
Approved: August 20, 2024 – Indoco Remedies Ltd.
Treatment for: Opiate Withdrawal
Generic for: Lucemyra - Riluzole Oral Suspension 50mg/10mL
Approved: August 22, 2024 – Alkem Laboratories Ltd.
Treatment for: Amyotrophic Lateral Sclerosis
Generic for: Tiglutik - Methylnaltrexone Bromide Subcutaneous Solution 8mg/0.4mL and 12mg/0.6mL
Approved: August 26, 2024 – Actavis Pharma, Inc.
Treatment for: Opioid-Induced Constipation
Generic for: Relistor - Amantadine Hydrochloride Extended-Release Capsules 68.5mg (base)
Approved: August 26, 2024 – Zydus Pharmaceuticals (USA) Inc.
Treatment for: Parkinson’s Disease
Generic for: Gocovr